ms KAREN LIPTON — Lobbyist Profile | Poliscope

ms KAREN LIPTON

Reported covered position: N/A

Filings

Clients

Firms

Years active

2002–2005

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO	4	2002–2005

Lobbying firms

Firm	Filings	Years
AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES	4	2002–2005

Bills explicitly cited in this lobbyist’s assigned issues (1)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

S. 1317

Stem Cell Therapeutic and Research Act of 2005

Client: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES

Open original LDA filing ↗

Cited source text

Cord blood bank initiatives (HR 2520; S 1317); Blood safety initiatives; Blood safety initiatives under the President's Emergency Plan for AIDS Relief

Original LDA source filings (4)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO via AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES

2005 · year_end · YY

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

MED

Medical/Disease Research/Clinical Labs

biomedical research funding

MMM

Medicare/Medicaid

Medicare reimbursement for blood products

HCR

Source: Senate LDA